Russian Heart Failure Journal 2014year Mechanical dyssynchrony in patients with chronic heart failure: Classification, methods of evaluation, and significance in selection of patients for cardiac resynchronization therapy


To access this material please log in or register

Register Authorize
2014/№2

Mechanical dyssynchrony in patients with chronic heart failure: Classification, methods of evaluation, and significance in selection of patients for cardiac resynchronization therapy

Stavtseva Yu. V., Villevalde S. V., Kobalava Zh. D.

Keywords: cardiac dyssynchrony, cardiac resynchronization therapy, CHF, ECG

DOI: 10.18087 / rhfj.2014.2.1909

Appearance of cardiac resynchronization therapy (CRT) has considerably influenced the strategy of managing CHF patients. The major limitation of this intervention is the absence of response in 30% of patients, which may evidence an inadequate specificity of selection criteria. The review considers methods for evaluation of mechanical dyssynchrony, which may optimize selection of patients for CRT.
  1. Stevenson WG, Hernandez AF, Carson PE et al. Indications for cardiac resynchronization therapy: 2011 update from the Heart Failure Society of America guideline committee. J Card Fail. 2012;18 (2):94–106.
  2. Birnie DH, Tang AS. The problem of non-response to cardiac resynchronization therapy. Curr Opin Cardiol. 2006;21 (1):20–26.
  3. Brignole M, Auricchio A, Baron-Esquivias G et al. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J. 2013;34 (29):2281–2329.
  4. Yu CM, Lin H, Zhang Q, Sanderson JE. High prevalence of left ventricular systolic and diastolic asynchrony in patients with congestive heart failure and normal QRS duration. Heart. 2003;89 (1):54–60.
  5. Yu CM, Yang H, Lau CP et al. Regional left ventricle mechanical asynchrony in patients with heart disease and normal QRS duration: implication for biventricular pacing therapy. Pacing Clin Electrophysiol 2003;26 (2 Pt 1). 562–570.
  6. Bax JJ, Ansalone G, Breithardt OA et al. Echocardiographic evaluation of cardiac resynchronization therapy: ready for routine clinical useA critical appraisal. J Am Coll Cardiol. 2004;44 (1):1–9.
  7. Chung ES, Leon AR, Tavazzi L et al. Results of the Predictors of Response to CRT (PROSPECT) trial. Circulation. 2008;117 (20):2608–2616.
  8. Yu CM, Sanderson JE, Gorcsan J 3rd. Echocardiography, dyssynchrony, and the response to cardiac resynchronization therapy. Eur Heart J. 2010;31 (19):2326–2337.
  9. Yu CM, Wing-Hong Fung J, Zhang Q, Sanderson JE. Understanding nonresponders of cardiac resynchronization therapy – current and future perspectives. J Cardiovasc Electrophysiol. 2005;16 (10):1117–1124.
  10. Bax JJ, Abraham T, Barold SS et al. Cardiac resynchronization therapy: Part 1--issues before device implantation. J Am Coll Cardiol. 2005;46 (12):2153–2167.
  11. Cleland J, Freemantle N, Ghio S et al. Predicting the long-term effects of cardiac resynchronization therapy on mortality from baseline variables and the early response a report from the CARE-HF (Cardiac Resynchronization in Heart Failure) Trial. J Am Coll Cardiol. 2008;52 (6):438–445.
  12. Zhang Q, van Bommel RJ, Fung JW et al. Tissue Doppler velocity is superior to strain imaging in predicting long-term cardiovascular events after cardiac resynchronisation therapy. Heart. 2009;95 (13):1085–1090.
  13. Oyenuga O, Hara H, Tanaka H et al. Usefulness of echocardiographic dyssynchrony in patients with borderline QRS duration to assist with selection for cardiac resynchronization therapy. JACC Cardiovasc Imaging. 2010;3 (2):132–140.
  14. van Bommel RJ, Borleffs CJ, Ypenburg C et al. Morbidity and mortality in heart failure patients treated with cardiac resynchronization therapy: influence of pre-implantation characteristics on long-term outcome. Eur Heart J. 2010;31 (22):2783–2790.
  15. Richardson M, Freemantle N, Calvert MJ et al. Predictors and treatment response with cardiac resynchronization therapy in patients with heart failure characterized by dyssynchrony: a pre-defined ana­lysis from the CARE-HF trial. Eur Heart J. 2007;28 (15):1827–1834.
  16. Shenkman HJ, Pampati V, Khandelwal AK et al. Congestive heart failure and QRS duration: establishing prognosis study. Chest. 2002;122 (2):528–534.
  17. Yu CM, Chan YS, Zhang Q et al. Benefits of cardiac resynchronization therapy for heart failure patients with narrow QRS complexes and coexisting systolic asynchrony by echocardiography. J Am Coll Cardiol. 2006;48 (11):2251–2257.
  18. Leon AR, Niazi I, Herrmann K et al. Chronic evaluation of CRT in narrow QRS patients with mechanical dyssynchrony from a multicenter study: ESTEEM–CRT. Paper presented at Heart Rhythm Society Congress; May 15, 2008; San Francisco, CA.
  19. Beshai JF, Grimm RA, Nagueh SF et al. Cardiac-resynchronization therapy in heart failure with narrow QRS complexes. N Engl J Med. 2007;357 (24):2461–2471.
  20. Trichon BH, Felker GM, Shaw LK et al. Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failure. Am J Cardiol. 2003;91 (5):538–543.
  21. Koelling T, Aaronson K, Cody R et al. Prognostic sighnificance of mitral regurgitation and tricuspidal regurgitation in patients with left ventricular systolic dysfunction. Am Heart J. 2002;144 (3):524–529.
  22. Vinereanu D. Mitral regurgitation and cardiac resynchronization therapy. Echocardiography. 2008;25 (10):1155–1166.
  23. Kanzaki H, Bazaz R, Schwartzman D et al. A mechanism for immediate reduction in mitral regurgitation after cardiac resynchronization therapy: insights from mechanical activation strain mapping. J Am Coll Cardiol. 2004;44 (8):1619–1625.
  24. Soyama A, Kono T, Mishima T et al. Intraventricular dyssynchrony may play a role in the development of mitral regurgitation in dilated cardiomyopathy. J Card Fail. 2005;11 (8):631–637.
  25. Langer F, Tibayan FA, Rodriguez F et al. Altered mitral valve kinematics with atrioventricular and ventricular pacing. J Heart Valve Dis. 2005;14 (3):286–294.
  26. Szymanski P, Klisiewicz A, Hoffman P. Asynchronous movement of mitral annulus: an additional mechanism of ischaemic mitral regurgitation. Clin Cardiol. 2007;30 (10):512–516.
  27. Liang YJ, Zhang Q, Fang F et al. Incremental value of global systolic dyssynchrony in determining the occurrence of functional mitral regurgitation in patients with left ventricular systolic dysfunction. Eur Heart J. 2013;34 (10):767–774.
  28. Ypenburg C, Lancellotti P, Tops LF et al. Mechanism of improvement in mitral regurgitation after cardiac resynchronization therapy. Eur Heart J. 2008;29 (6):757–765.
  29. Breithardt OA, Sinha AM, Schwammenthal E et al. Acute effects of cardiac resynchronization therapy on functional mitral regurgitation in advanced systolic heart failure. J Am Coll Cardiol. 2003;41 (5):765–770.
  30. St John Sutton MG, Plappert T, Abraham WT et al. Multicenter InSync Randomized Clinical Evaluation (MIRACLE) Study Group. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation. 2003;107 (15):1985–1990.
  31. Ypenburg C, Lancellotti P, Tops LF et al. Acute effects of initiation and withdrawal of cardiac resynchronization therapy on papillary muscle dyssynchrony and mitral regurgitation. J Am Coll Cardiol. 2007;50 (21):2071–2077.
  32. Angeja BG, Grossman W. Evaluation and management of diastolic heart failure. Circulation. 2003 Feb 11;107 (5):659–663.
  33. Yu CM, Zhang Q, Yip GW et al. Diastolic and systolic asynchrony in patients with diastolic heart failure: a common but ignored condition. J Am Coll Cardiol. 2007;49 (1):97–105.
  34. Lee AP, Zhang Q, Yip G et al. LV mechanical dyssynchrony in heart failure with preserved ejection fraction complicating acute coronary syndrome. JACC Cardiovasc Imaging. 2011;4 (4):348–357.
  35. Lee AP, Song JK, Yip GW, et al. Importance of dynamic dyssynchrony in the occurrence of hypertensive heart failure with normal ejection fraction. Eur Heart J. 2010;31 (21):2642–2649.
  36. Wang J, Kurrelmeyer KM, Torre-Amione G, Nagueh SF. Systolic and diastolic dyssynchrony in patients with diastolic heart failure and the effect of medical therapy. J Am Coll Cardiol. 2007;49 (1):88–96.
  37. Bader H, Garrigue S, Lafitte S et al. Intra-left ventricular electromechanical asynchrony. A new independent predictor of severe cardiac events in heart failure patients. J Am Coll Cardiol. 2004;43 (2):248–256.
  38. Cho GY, Song JK, Park WJ et al. Mechanical dyssynchrony assessed by tissue Doppler imaging is a powerful predictor of mortality in congestive heart failure with normal QRS duration. J Am Coll Cardiol. 2005;46 (12):2237–2243.
  39. Cho GY, Kim HK, Kim YJ, et al. Electrical and mechanical dyssynchrony for prediction of cardiac events in patients with systolic heart failure. Heart. 2010;96 (13):1029–1032.
  40. Shin SH, Hung CL, Uno H et al. Valsartan in Acute Myocardial Infarction Trial (VALIANT) Investigators. Mechanical dyssynchrony after myocardial infarction in patients with left ventricular dysfunction, heart failure, or both. Circulation. 2010;121 (9):1096–1103.
  41. Penicka M, Bartunek J, Lang O et al. Severe left ventricular dyssynchrony is associated with poor prognosis in patients with moderate systolic heart failure undergoing coronary artery bypass grafting. J Am Coll Cardiol. 2007;50 (14):1315–1323.
  42. Pitzalis MV, Iacoviello M, Romito R et al. Ventricular asynchrony predicts a better outcome in patients with chronic heart failure receiving cardiac resynchronization therapy. J Am Coll Cardiol. 2005;45 (1):65–69.
  43. Díaz-Infante E, Sitges M, Vidal B et al. Usefulness of ventricular dyssynchrony measured using M-mode echocardiography to predict response to resynchronization therapy. Am J Cardiol. 2007;100 (1):84–89.
  44. Parisi AF, Moynihan PF, Folland ED, Feldman CL. Quantitative detection of regional left ventricular contraction abnormalities by two-dimensional echocardiography, II. Accuracy in coronary artery disease. Circulation. 1981;63 (4):761–767.
  45. Perk G, Tunick PA, Kronzon I. Non-Doppler two-dimensional strain imaging by echocardiography--from technical considerations to cli­nical applications. J Am Soc Echocardiogr. 2007;20 (3):234–243.
  46. Waggoner AD, Bierig SM. Tissue Doppler imaging: a useful echocardiographic method for the cardiac sonographer to assess systolic and diastolic ventricular function. J Am Soc Echocardiogr. 2001;14 (12):1143–1152.
  47. Bax JJ, Bleeker GB, Marwick TH et al. Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy. J Am Coll Cardiol. 2004;44 (9):1834–1840.
  48. Yu CM, Fung JW, Zhang Q et al. Tissue Doppler imaging is superior to strain rate imaging and postsystolic shortening on the prediction of reverse remodeling in both ischemic and nonischemic heart failure after cardiac resynchronization therapy. Circulation. 2004;110 (1):66–73.
  49. van Bommel RJ, Bax JJ, Abraham WT et al. Characteristics of heart failure patients associated with good and poor response to cardiac resynchronization therapy: a PROSPECT (Predictors of Response to CRT) sub-analysis. Eur Heart J. 2009;30 (20):2470–2477.
  50. Marwick TH. Measurement of strain and strain rate by echocardiography: ready for prime time. J Am Coll Cardiol. 2006 Apr 4;47 (7):1313–1327.
  51. Modesto KM, Cauduro S, Dispezieri A et al. Two-dimensional acoustic pattern derived strain parameters closely correlate with one-dimensional tissue Doppler derived strain measurements. Eur J Echocardiogr. 2006;7 (4):315–321.
  52. Delgado V, Ypenburg C, van Bommel RJ et al. Assessment of left ventricular dyssynchrony by speckle tracking strain imaging comparison between longitudinal, circumferential, and radial strain in cardiac resynchronization therapy. J Am Coll Cardiol. 2008;51 (20):1944–1952.
  53. Perk G, Tunick PA, Kronzon I. Non-Doppler two-dimensional strain imaging by echocardiography – from technical conside­rations to clinical applications. J Am Soc Echocardiogr. 2007;20 (3):234–243.
  54. Ingul CB, Torp H, Aase SA et al. Automated analyses of strain rate and strain: feasibility and clinical implications. J Am Soc Echocardiogr. 2005;18 (5):411–418.
  55. Marsan NA, Bleeker GB, Ypenburg C et al. Real-time three-dimensional echocardiography permits quantification of left ventricular mechanical dyssynchrony and predicts acute response to cardiac resynchronization therapy. J Cardiovasc Electrophysiol. 2008;19 (4):392–399.
  56. Yu CM, Bleeker GB, Fung JW et al. Left ventricular reverse remo­deling but not clinical improvement predicts long-term survival after cardiac resynchronization therapy. Circulation. 2005;112 (11):1580–1586.
  57. Deplagne A, Bordachar P, Reant P et al. Additional value of three-dimensional echocardiography in patients with cardiac resynchronization therapy. Arch Cardiovasc Dis. 2009;102 (6-7):497–508.
Stavtseva Yu. V., Villevalde S. V., Kobalava Zh. D. Mechanical dyssynchrony in patients with chronic heart failure: Classification, methods of evaluation, and significance in selection of patients for cardiac resynchronization therapy. Russian Heart Failure Journal. 2014;83 (2):101–109

To access this material please log in or register

Register Authorize
Ru En